ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q3SCImago #17,367Diamond OAHybrid

Leprosy Review

Abbreviation (ISO):LEPROSY REV
•
Identifier (ISSN):0305-7518(Print)/2162-8807(Online)
•
Publisher:British Leprosy Relief Association
Clarivate IF (2026)
1.3↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Leprosy Review

WoS Q3
01120.7520180.5420190.6620200.5420210.5520220.620230.820240.820251.32026
Annual Impact Factor Metric
Current (2026):1.3
Scopus SJR & RankScopus Q3
0.295
#17,367

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
53

53 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate37.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
40articles/year
99.04% Gold OA•83.78% Original Research

Aims & Scope

Leprosy Review is an Open Access peer reviewed journal including original papers on all aspects of leprosy. Topics published include research into the medical, physical and social aspects of leprosy and information relevant to leprosy control. We publish original research, short reports, case studies and reviews. The vision of the journal is to improve the management and control of leprosy and its consequences, by publishing relevant research and sharing experiences and best practices.

Topics Covered (Recognized by AI)
MedicineBiologyPathologyImmunologyInternal MedicineFamily MedicineSurgery
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

DERMATOLOGY

Q3
Rank71/99
IndexSCIE
JCRSCIE2026

INFECTIOUS DISEASES

Q4
Rank118/141
IndexSCIE
JCRSCIE2026

PATHOLOGY

Q3
Rank64/89
IndexSCIE
JCRSCIE2026

TROPICAL MEDICINE

Q4
Rank21/27
IndexSCIE
JCISCIE2026

DERMATOLOGY

Q4
Rank79/99
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q4
Rank118/141
IndexSCIE
JCISCIE2026

PATHOLOGY

Q4
Rank74/89
IndexSCIE
JCISCIE2026

TROPICAL MEDICINE

Q4
Rank23/27
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.3
Articles / Year29
Total Citations0
2025
IF0.8
Articles / Year61
Total Citations16
2024
IF0.8
Articles / Year60
Total Citations54
2023
IF0.6
Articles / Year53
Total Citations113
2022
IF0.548
Articles / Year51
Total Citations202

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,367Scopus Q3Diamond OASCImago Profile
Scopus Coverage:1945-1948, 1950-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.295

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.69

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations121
3-Year Documents154
Citable Documents112

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

DermatologyQ3
Infectious DiseasesQ3
Medicine (miscellaneous)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 37.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区DERMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Leprosy Review (abbr: LEPROSY REV, ISSN: 0305-7518) is a peer-reviewed international scholarly journal in the field of Medicine, published by British Leprosy Relief Association in England since 1930. The periodical holds a Journal Impact Factor (JIF) of 1.30, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.295 (Q3), an H-index of 53.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 40 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
British Leprosy Relief Association
Publication Language
English
Frequency
Quarterly
Founding Year
1930
Indexing & Databases
SCIEScopusPubMed
Editorial Address
LEPRA, 28 MIDDLEBOROUGH, COLCHESTER, ENGLAND, ESSEX, CO1 1TG

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5d58c14c-d69f-4eb0-a0d1-8f7d6bce1d78
Database Updated: 2026-09-28